» Articles » PMID: 29721826

Importance of Differential Identification of Mycobacterium Tuberculosis Strains for Understanding Differences in Their Prevalence, Treatment Efficacy, and Vaccine Development

Overview
Journal J Microbiol
Specialty Microbiology
Date 2018 May 4
PMID 29721826
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a serious global health problem in the 21 century because of its high mortality. Mtb is an extremely successful human-adapted pathogen that displays a multifactorial ability to control the host immune response and to evade killing by drugs, resulting in the breakdown of BCG vaccine-conferred anti-TB immunity and development of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb. Although genetic components of the genomes of the Mtb complex strains are highly conserved, showing over 99% similarity to other bacterial genera, recently accumulated evidence suggests that the genetic diversity of the Mtb complex strains has implications for treatment outcomes, development of MDR/XDR Mtb, BCG vaccine efficacy, transmissibility, and epidemiological outbreaks. Thus, new insights into the pathophysiological features of the Mtb complex strains are required for development of novel vaccines and for control of MDR/XDR Mtb infection, eventually leading to refinement of treatment regimens and the health care system. Many studies have focused on the differential identification of Mtb complex strains belonging to different lineages because of differences in their virulence and geographical dominance. In this review, we discuss the impact of differing genetic characteristics among Mtb complex strains on vaccine efficacy, treatment outcome, development of MDR/XDR Mtb strains, and epidemiological outbreaks by focusing on the best-adapted human Mtb lineages. We further explore the rationale for differential identification of Mtb strains for more effective control of TB in clinical and laboratory settings by scrutinizing current diagnostic methods.

Citing Articles

Comparative growth kinetics and drug susceptibility of lineages prevalent in Ethiopia: implications for tuberculosis treatment and management.

Hailemariam T, Tilahun M, Atnafu A, Gelanew T, Gebresilase T, Tola M Front Microbiol. 2025; 15:1512580.

PMID: 39968044 PMC: 11832462. DOI: 10.3389/fmicb.2024.1512580.


Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification.

Zhang H, Tang M, Li D, Xu M, Ao Y, Lin L Front Public Health. 2024; 12:1410672.

PMID: 38962772 PMC: 11220129. DOI: 10.3389/fpubh.2024.1410672.


Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review.

Zhang H, Liao Y, Zhu Z, Liu H, Li D, Wang S Front Cell Infect Microbiol. 2024; 14:1341236.

PMID: 38410723 PMC: 10894915. DOI: 10.3389/fcimb.2024.1341236.


Tuberculosis prevention: current strategies and future directions.

Vasiliu A, Martinez L, Gupta R, Hamada Y, Ness T, Kay A Clin Microbiol Infect. 2023; 30(9):1123-1130.

PMID: 37918510 PMC: 11524220. DOI: 10.1016/j.cmi.2023.10.023.


Will we ever eradicate animal tuberculosis?.

Gortazar C, de la Fuente J, Perello A, Dominguez L Ir Vet J. 2023; 76(Suppl 1):24.

PMID: 37737206 PMC: 10515422. DOI: 10.1186/s13620-023-00254-9.


References
1.
Rook G, Bahr G, Stanford J . The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle. 1981; 62(1):63-8. DOI: 10.1016/0041-3879(81)90038-6. View

2.
Achtman M . Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu Rev Microbiol. 2008; 62:53-70. DOI: 10.1146/annurev.micro.62.081307.162832. View

3.
Galagan J . Genomic insights into tuberculosis. Nat Rev Genet. 2014; 15(5):307-20. DOI: 10.1038/nrg3664. View

4.
Yimer S, Hailu E, Derese Y, Bjune G, Holm-Hansen C . Spoligotyping of Mycobacterium tuberculosis isolates among pulmonary tuberculosis patients in Amhara Region, Ethiopia. APMIS. 2013; 121(9):878-85. DOI: 10.1111/apm.12046. View

5.
Newton S, Smith R, Wilkinson K, Nicol M, Garton N, Staples K . A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci U S A. 2006; 103(42):15594-8. PMC: 1622867. DOI: 10.1073/pnas.0604283103. View